JP2003531196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003531196A5 JP2003531196A5 JP2001578413A JP2001578413A JP2003531196A5 JP 2003531196 A5 JP2003531196 A5 JP 2003531196A5 JP 2001578413 A JP2001578413 A JP 2001578413A JP 2001578413 A JP2001578413 A JP 2001578413A JP 2003531196 A5 JP2003531196 A5 JP 2003531196A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- ethyl
- hydrogen
- methyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 7
- -1 ter-butyl Chemical group 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 0 *CC(C(*)*N(C(C(*)(*)C(N1*)=O)=O)C1=*)C(**I)I Chemical compound *CC(C(*)*N(C(C(*)(*)C(N1*)=O)=O)C1=*)C(**I)I 0.000 description 1
- SUMOGQRIFUNWJT-UHFFFAOYSA-N 1-(1-bicyclo[2.2.1]heptanyloxy)-5-ethyl-3-methyl-5-(3-methylbutyl)-2-sulfanylidene-1,3-diazinane-4,6-dione Chemical compound C12(CCC(CC1)C2)ON2C(N(C(C(C2=O)(CCC(C)C)CC)=O)C)=S SUMOGQRIFUNWJT-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZEFARIUQGUQFTK-UHFFFAOYSA-N 5,5-dibutyl-1-(2,2-dimethylpropoxy)-3-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione Chemical compound C(C(C)(C)C)ON1C(N(C(C(C1=O)(CCCC)CCCC)=O)C)=S ZEFARIUQGUQFTK-UHFFFAOYSA-N 0.000 description 1
- UPFTUZHVZCZEQZ-UHFFFAOYSA-N 5-propyl-2-sulfanylidene-1,3-diazinane-4,6-dione Chemical compound CCCC1C(=O)NC(=S)NC1=O UPFTUZHVZCZEQZ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- URQXRAAARGQOKM-UHFFFAOYSA-N ethyl 2-(5,5-diethyl-4,6-dioxo-2-sulfanylidene-1,3-diazinan-1-yl)acetate Chemical compound CCOC(=O)CN1C(=S)NC(=O)C(CC)(CC)C1=O URQXRAAARGQOKM-UHFFFAOYSA-N 0.000 description 1
- NHVFBNFYDYTTTO-UHFFFAOYSA-N ethyl 2-[5-ethyl-5-(3-methylbutyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-1-yl]acetate Chemical compound CCOC(=O)CN1C(=S)NC(=O)C(CC)(CCC(C)C)C1=O NHVFBNFYDYTTTO-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- KTNZFEZLTBVXGD-UHFFFAOYSA-N methyl 2-(5-ethyl-4,6-dioxo-5-pentan-2-yl-2-sulfanylidene-1,3-diazinan-1-yl)dodecanoate Chemical compound CCCCCCCCCCC(C(=O)OC)N1C(=S)NC(=O)C(CC)(C(C)CCC)C1=O KTNZFEZLTBVXGD-UHFFFAOYSA-N 0.000 description 1
- PMBKOGIKHUILRH-UHFFFAOYSA-N methyl 4,6-dioxo-5,5-dipropyl-2-sulfanylidene-1,3-diazinane-1-carboxylate Chemical compound CCCC1(CCC)C(=O)NC(=S)N(C(=O)OC)C1=O PMBKOGIKHUILRH-UHFFFAOYSA-N 0.000 description 1
- JBGWPXADKMSYCM-UHFFFAOYSA-N methyl 5,5-dibutyl-4,6-dioxo-2-sulfanylidene-1,3-diazinane-1-carboxylate Chemical compound CCCCC1(CCCC)C(=O)NC(=S)N(C(=O)OC)C1=O JBGWPXADKMSYCM-UHFFFAOYSA-N 0.000 description 1
- PQGDOZNCTTUBPP-UHFFFAOYSA-N methyl 5,5-diethyl-4,6-dioxo-2-sulfanylidene-1,3-diazinane-1-carboxylate Chemical compound CCC1(CC)C(=O)NC(=S)N(C(=O)OC)C1=O PQGDOZNCTTUBPP-UHFFFAOYSA-N 0.000 description 1
- ONDNNUONGXRXNS-UHFFFAOYSA-N methyl 5-ethyl-4,6-dioxo-5-pentan-2-yl-2-sulfanylidene-1,3-diazinane-1-carboxylate Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)N(C(=O)OC)C1=O ONDNNUONGXRXNS-UHFFFAOYSA-N 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19914400P | 2000-04-24 | 2000-04-24 | |
| US60/199,144 | 2000-04-24 | ||
| PCT/US2001/013246 WO2001081319A2 (en) | 2000-04-24 | 2001-04-24 | Ultrashort acting hypnotic barbiturates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003531196A JP2003531196A (ja) | 2003-10-21 |
| JP2003531196A5 true JP2003531196A5 (enExample) | 2008-06-19 |
Family
ID=22736404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001578413A Pending JP2003531196A (ja) | 2000-04-24 | 2001-04-24 | 超短時間作用型催眠性バルビツール酸塩 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US6387914B2 (enExample) |
| EP (1) | EP1276728A2 (enExample) |
| JP (1) | JP2003531196A (enExample) |
| AU (2) | AU5723001A (enExample) |
| CA (1) | CA2404898A1 (enExample) |
| WO (1) | WO2001081319A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1276728A2 (en) * | 2000-04-24 | 2003-01-22 | ARYx Therapeutics | Ultrashort acting hypnotic barbiturates |
| US7049326B2 (en) * | 2000-05-12 | 2006-05-23 | The University Of Toledo | Method and compositions for temporarily incapacitating subjects |
| US6756047B2 (en) * | 2000-05-12 | 2004-06-29 | The University Of Toledo | Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| US6750238B1 (en) * | 2000-05-12 | 2004-06-15 | The University Of Toledo | Aralkyl ester soft drugs |
| US10537061B2 (en) * | 2010-02-26 | 2020-01-21 | Cnh Industrial America Llc | System and method for controlling harvest operations |
| WO2014014960A1 (en) * | 2012-07-16 | 2014-01-23 | Dignity Health | Treating of epilepsy and alcohol addiction with creatine |
| CA2961410C (en) | 2014-09-16 | 2023-07-11 | India Globalization Capital, Inc. | Cannabinoid composition and method for treating pain |
| EP3247359A4 (en) | 2015-01-25 | 2018-08-08 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
| US10596159B2 (en) | 2015-08-12 | 2020-03-24 | India Globalization Capital, Inc. | Method and composition for treating cachexia and eating disorders |
| EP3471746A4 (en) | 2016-06-15 | 2020-02-26 | India Globalization Capital, Inc. | METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2405732A1 (de) * | 1974-02-07 | 1975-08-21 | Bayer Ag | Ekto- und endoparasitenmittel |
| CS176667B1 (enExample) * | 1975-02-17 | 1977-06-30 | ||
| IL73840A (en) * | 1983-12-19 | 1988-11-15 | Uniroyal Chem Co Inc | 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them |
| DE69032871T2 (de) * | 1989-11-14 | 1999-09-09 | Sloan-Kettering Institute For Cancer Research | Neue potente induktoren terminaler differenzierung und verfahren zu ihrer verwendung |
| CH678394A5 (enExample) * | 1990-08-22 | 1991-09-13 | Cerny Erich H | |
| US5414085A (en) * | 1992-04-06 | 1995-05-09 | Biosite Diagnostics, Inc. | Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| JPH06214344A (ja) * | 1992-10-22 | 1994-08-05 | Konica Corp | ハロゲン化銀写真感光材料 |
| JPH07120865A (ja) * | 1993-10-21 | 1995-05-12 | Konica Corp | ハロゲン化銀写真感光材料 |
| US6335332B1 (en) * | 1997-06-21 | 2002-01-01 | Roche Diagnostics Gmbh | Barbituric acid derivatives with antimetastatic and antitumor activity |
| EP1276728A2 (en) * | 2000-04-24 | 2003-01-22 | ARYx Therapeutics | Ultrashort acting hypnotic barbiturates |
-
2001
- 2001-04-24 EP EP01930722A patent/EP1276728A2/en not_active Withdrawn
- 2001-04-24 US US09/841,738 patent/US6387914B2/en not_active Expired - Fee Related
- 2001-04-24 WO PCT/US2001/013246 patent/WO2001081319A2/en not_active Ceased
- 2001-04-24 CA CA002404898A patent/CA2404898A1/en not_active Abandoned
- 2001-04-24 JP JP2001578413A patent/JP2003531196A/ja active Pending
- 2001-04-24 AU AU5723001A patent/AU5723001A/xx active Pending
- 2001-04-24 AU AU2001257230A patent/AU2001257230B2/en not_active Ceased
-
2002
- 2002-05-13 US US10/145,601 patent/US6683086B2/en not_active Expired - Fee Related
-
2004
- 2004-01-23 US US10/763,904 patent/US7041673B2/en not_active Ceased
-
2007
- 2007-12-20 US US12/009,446 patent/USRE41289E1/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890011853A (ko) | 치환된 피롤, 피라졸 및 트리아졸 안지오텐신ⅱ 길항제 | |
| RU2436780C2 (ru) | Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы | |
| CA2436846A1 (en) | Thioether substituted imidazoquinolines | |
| CA2440473A1 (en) | Metalloproteinase inhibitors | |
| JP2001526218A5 (enExample) | ||
| JP2003531196A5 (enExample) | ||
| JP2002502874A5 (enExample) | ||
| RU96115142A (ru) | Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов | |
| KR880002840A (ko) | 이미다졸 화합물, 그의 제조 방법 및 이것으로 되는 제약 조성물 | |
| EP1797878A3 (en) | Benzothiazole derivatives | |
| KR960704884A (ko) | 항종양제 또는 항바이러스제로서의 디스타마이신 A 동족체 (Distamycin A analogues as antitumour or antiviral agents) | |
| EP2228064A3 (en) | Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist | |
| SK95093A3 (en) | Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b | |
| CA2281426A1 (en) | Substituted indole compounds as anti-inflammatory and analgesic agents | |
| RU2006146632A (ru) | Производные хиназолинона, полезные в качестве ванилоидных антагонистов | |
| JP2002519425A5 (enExample) | ||
| CA2539738A1 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| RU2000123169A (ru) | Бензотиадиазолы и их производные | |
| CA2440014A1 (en) | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety | |
| RU2001105092A (ru) | Имидазольные соединения и их применение в качестве ингибиторов аденозиндезаминазы | |
| JP2004525178A5 (enExample) | ||
| CA2643005A1 (en) | Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof | |
| JP2004525183A5 (enExample) | ||
| CA2433039A1 (en) | Agent for therapeutic and prophylactic treatment of neuropathic pain | |
| RU96123227A (ru) | Амидные производные и их терапевтическое использование |